<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-15T01:49:29Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.j00217.12016" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.j00217.12016</identifier>
    <datestamp>2026-02-24T15:14:00Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-02-24</dc:date>
  <dc:title>Effects of Clostridium sporogenes on Myeloid-Derived Suppressor Cells and Inflammatory Factors in Mice with Graves' Disease</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.j00217.12016</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Objective This study was designed to analyze the effects of Clostridium sporogenes (C. sporogenes) on myeloid-derived suppressor cells (MDSCs) and inflammatory factors in mice with Graves disease (GD).Methods A GD mice model was constructed using recombinant adenovirus overexpressing Ad-hTSHR-289 in 6-week-old female BALB/C mice. After modeling, the mice were randomly divided into 6 groups (8 mice/group): blank control group (CON), C. sporogenes intervention negative control group (CON_C.sp), C. sporogenes supernatant intervention negative control group (CON_C.sp_supernate), GD model group (MOD), C. sporogenes intervention GD model group (MOD_C.sp) and C. sporogenes supernatant intervention GD model group (MOD_ C.sp_supernate), and gave normal saline (NS). C. sporogenes or C. sporogenes supernatant was gavaged intervention for 6 weeks, the proportions of MDSCs and their subtype monocyte-like myeloid-derived suppressor cells M-MDSCs in spleen were respectively detected by flow cytometry. The expression levels of tumor necrosis factor -&amp;alpha; (TNF-&amp;alpha;), interleukin-6 (IL-6), interleukin-10 (IL-10), free thyroxine (FT4), thyroid-stimulating hormone receptor antibody (TRAb) and thyroid-stimulating hormone (TSH) in plasma were determined by ELISA. Pearson method was used to analyze the correlation among MDSCs, M-MDSCs, inflammatory cytokines and thyroxine.Results Compared with the model group mice, the proportion of M-MDSCs in GD model group (MOD_C.sp_supernate) treated with C. sporogenes supernatant was increased in spleen. The plasma TNF-&amp;alpha; and IL-6 of the GD model group (MOD_C.sp and MOD_C.sp_supernate) treated with C. sporogenes and their supernatant were decreased, and IL-10 was increased. Analysis of the correlation between Spleen MDSCs, M-MDSCs and plasma inflammatory cytokines showed that spleen MDSCs and M-MDSCs were negatively correlated with plasma TNF-&amp;alpha; and IL-6, but positively correlated with IL-10. Spleen MDSCs and M-MDSCs were negatively correlated with plasma FT4 and TRAb, but positively correlated with TSH.Conclusion C. sporogenes can increase the proportion of M-MDSCs in the spleen of GD mice, and improve GD inflammatory response in mice.</dc:description>
  <dc:subject>Clostridium sporogenes; Graves disease; MDSCs; M-MDSCs; Inflammation</dc:subject>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:creator>null.null</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>